GOLDENWELL BIOTECH, INC. (GWLL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 20K 40K 60K FY21: 16K FY22: 47.8K FY23: 1.8K FY24: 139 FY25: 55 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 9K 18K 27K FY21: 8.4K FY22: 25.2K FY23: 666 FY24: 64 FY25: 12 FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-1.1M -700K -350K 0 350K 700K 1.1M FY21: -118.3K FY22: -985.1K FY23: -115.8K FY24: -123.1K FY25: -113.3K FY21 FY22 FY23 FY24 FY25

Net Income Annual

-1.1M -700K -350K 0 350K 700K 1.1M FY21: -117K FY22: -985.1K FY23: -117.4K FY24: -131.5K FY25: -296.5K FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 8K 16K 24K FY21: 7.6K FY22: 22.6K FY23: 1.2K FY24: 75 FY25: 43 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-1.2M -800K -400K 0 400K 800K 1.2M FY21: -205.1K FY22: -1.1M FY23: -113.2K FY24: -123.1K FY25: -22.6K FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Annual

0 35M 70M 105M FY23: 99M FY24: 99M FY25: 99M FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 Q2 '20: 0.00 Q3 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '20 Q4 '20 Q2 '21 Q4 '21 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.